Results Snapshot
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Jun 2025 is 22.72% vs -0.11% in Jun 2024
Consolidate Net Profit
YoY Growth in quarter ended Jun 2025 is 65.50% vs -44.75% in Jun 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Jun 2025 is 54.93% vs -12.38% in Jun 2024
Interest
YoY Growth in quarter ended Jun 2025 is -48.00% vs 316.67% in Jun 2024
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Jun 2025 has improved from Jun 2024
Compare Quarterly Results Of Bide Pharmatech Co., Ltd. With
Quarterly - Net Sales
QoQ Growth in quarter ended Jun 2025 is 11.49% vs 2.47% in Mar 2025
YoY Growth in quarter ended Jun 2025 is 22.72% vs -0.11% in Jun 2024
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Jun 2025 is 39.09% vs -8.63% in Mar 2025
YoY Growth in quarter ended Jun 2025 is 65.50% vs -44.75% in Jun 2024
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Jun 2025 is 18.09% vs 32.26% in Mar 2025
YoY Growth in quarter ended Jun 2025 is 54.93% vs -12.38% in Jun 2024
Quarterly - Interest
QoQ Growth in quarter ended Jun 2025 is -40.91% vs 0.00% in Mar 2025
YoY Growth in quarter ended Jun 2025 is -48.00% vs 316.67% in Jun 2024
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Jun 2025 has improved from Mar 2025
YoY Growth in quarter ended Jun 2025 has improved from Jun 2024






